Edition:
United Kingdom

Intersect Ent Inc (XENT.OQ)

XENT.OQ on NASDAQ Stock Exchange Global Market

29.20USD
8:59pm GMT
Change (% chg)

$-0.08 (-0.27%)
Prev Close
$29.28
Open
$29.12
Day's High
$29.33
Day's Low
$28.86
Volume
71,041
Avg. Vol
103,360
52-wk High
$42.90
52-wk Low
$25.15

Chart for

About

Intersect ENT, Inc. is a commercial-stage drug-device company. The Company develops drugs for patients with ear, nose and throat (ENT) conditions. The Company has developed a drug releasing bioabsorbable implant technology that enables targeted and sustained release of therapeutic agents. This targeted drug delivery technology... (more)

Overall

Beta: --
Market Cap(Mil.): $894.66
Shares Outstanding(Mil.): 29.19
Dividend: --
Yield (%): --

Financials

  XENT.OQ Industry Sector
P/E (TTM): -- 32.17 33.71
EPS (TTM): -0.70 -- --
ROI: -16.93 13.75 14.48
ROE: -17.07 16.50 15.99

Earnings vs. Estimates